High-dose ursodeoxycholic acid for the t
โ
Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 319 KB
๐ 1 views
Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve